Novel potent azetidine-based compounds irreversibly inhibit Stat3 activation and induce antitumor response against human breast tumor growth in vivoPeibin Yue, James Turkson, Songqin Pan et al.|Cancer Letters|2022Cited by 21
Azetidine ring, salicylic acid, and salicylic acid bioisosteres as determinants of the binding characteristics of novel potent compounds to Stat3Yue Chen, James Turkson, Ning Zhai et al.|Bioorganic & Medicinal Chemistry Letters|2023Cited by 5
Abstract 2782: Small molecule H182 suppresses Stat3 activation in tumor cells and combines with radiation therapy to block breast tumor growth in mouse syngeneic modelsYue Chen, James Turkson, Peibin Yue et al.|Cancer Research|2023Cited by 0
Abstract 663: Irreversible covalent azetidine-based small molecule inhibitors of Stat3 activity block growth of human pancreatic tumorsYue Chen, James Turkson, Ning Zhai et al.|Cancer Research|2024Cited by 0
Abstract 1741: STAT3 Orchestrates common and divergent mechanisms in different cell types to promote pancreatic cancer development and progressionMonday O. Ogese, James Turkson, Lihong Huo et al.|Cancer Research|2025Cited by 0